ANKS3 Inhibitors
Chemicals classified as ANKS3 inhibitors are agents that can indirectly impact the function of the protein ANKS3 by modulating various cellular pathways. ANKS3 is a protein that is likely involved in cell signaling, and its precise biological functions are not fully understood. However, it is reasonable to assume that it operates within complex signaling networks that can be influenced by changes in the cellular environment caused by various chemical agents.
Inhibitors such as LY294002 and Wortmannin are known to target the PI3K/AKT pathway, a critical signaling route that regulates cell survival, growth, and proliferation. By inhibiting this pathway, these compounds can induce changes in the cellular state that may, in turn, affect the role of ANKS3. Similarly, U0126 and PD98059 are inhibitors of the MEK enzyme which in turn affects the MAPK/ERK pathway, another key signaling mechanism in cells. This pathway is integral to cell division, differentiation, and response to stress stimuli, and its modulation can influence ANKS3's interaction with other cellular components.
SB203580 and SP600125 are inhibitors of the MAPK pathways (p38 and JNK, respectively), which are involved in the cellular response to cytokines and stress. By inhibiting these pathways, these compounds can alter the cellular environment in which ANKS3 functions, potentially modulating its activity. Rapamycin is an mTOR inhibitor and is involved in controlling cell growth and autophagy. As such, it can affect the cellular processes where ANKS3 might play a part. Cyclosporin A, Thapsigargin, 2-APB, and BAPTA-AM are agents that influence calcium signaling within the cell. Calcium signaling is vital for various cellular functions, including muscle contraction, neurotransmitter release, and cell growth. By altering this signaling, these compounds can indirectly affect the role of ANKS3 in calcium-dependent signaling processes. Lastly, KN-93, a CaMKII inhibitor, has the potential to modulate calcium/calmodulin-dependent processes, thereby influencing ANKS3's associated signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, can alter AKT signaling which is involved in cellular survival and may indirectly affect ANKS3's functions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, can disrupt downstream AKT signaling pathways that can be related to ANKS3 activities. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, can affect the MAPK/ERK pathway, potentially altering signaling pathways where ANKS3 may be involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, can modify the inflammatory response and stress signaling pathways that ANKS3 might be part of. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can influence cell growth and autophagy pathways, potentially affecting processes where ANKS3 is implicated. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor, can affect T-cell activation and other signaling pathways that may interact with ANKS3's role. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor, can lead to increased cytosolic calcium levels, possibly impacting ANKS3-related calcium signaling. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
IP3 receptor blocker, can modify calcium signaling pathways and potentially influence ANKS3's involvement in these pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator, can alter intracellular calcium levels, potentially affecting calcium-dependent processes involving ANKS3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Specific MEK inhibitor, can change the MAPK/ERK signaling, which may indirectly affect ANKS3's activities. | ||||||